ClearPoint Neuro, Inc.

02/02/2026

Neuro is starting 2026 strong with a team of over 170 people focused entirely on Neuro. We’re excited to keep this momentum going and see what we can achieve together!

01/22/2026

Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe - Read more here: https://loom.ly/EfJuDX0

ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe January 22, 2026 4:30pm EST Download as PDF SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro,....

01/20/2026

Neuro was excited to take part in the recent Neurosurgery Research Consortium. Our new Chief Medical Officer - Dr. Paul Larson - got a chance to share his vision for advancing our Biologics and Drug Delivery development programs.

11/20/2025

ClearPoint Neuro Completes Acquisition of IRRAS - Read more here: https://loom.ly/ualabV8

ClearPoint Neuro Completes Acquisition of IRRAS November 20, 2025 5:00pm EST Download as PDF Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire / Novem...

11/06/2025

ClearPoint Neuro Reports Third Quarter 2025 Results - Read More Here: https://loom.ly/8gwEkRA

ClearPoint Neuro Reports Third Quarter 2025 Results November 06, 2025 4:55pm EST Download as PDF Site Readiness Continues for Specialized Treatment Centers Envisioned to Support a Growing Number of Cell and Gene Therapy Trial Patients and Later Commercialization SOLANA BEACH, CA / ACCESS Newswire /....

11/06/2025

ClearPoint Neuro Announces Agreement to Acquire IRRAS - Read More Here: https://loom.ly/dLij52s

ClearPoint Neuro Announces Agreement to Acquire IRRAS November 06, 2025 4:50pm EST Download as PDF Acquisition Will Further Expand the Potential of ClearPoint Neuro's Drug Delivery Portfolio While Immediately Adding New Indications and Commercial Scale Across a $0.5 Billion Market for the Treatment....

10/25/2025

Our clinical education & training team always appreciates the invitation to participate in the Stereotactic & Functional Neurosurgery Hands-on Course at University of Colorado Anschutz. This year marks the debut of ’s new iCT-guidance option & 1.5T labeling for the Laser Therapy System. We appreciate the faculty & trainees and Kara Kittelberger & Paul Stehr for their dedication to advancing neurosurgical techniques & training.

10/24/2025

For the first time, Neuro has been named one of America’s Growth Leaders by TIME!

This recognition highlights the growing impact of our team and products—not just in cell and gene therapy, but across the field of neurosurgery. Several key programs are converging to drive an increasing global impact, and we’re excited to see what’s next!


https://loom.ly/NuC_f2o

10/13/2025

Neuro has grown & evolved so much over these past several years. We have so much more planned looking ahead & now with the right team, resources, & partnerships in place. That is why we call this next chapter for us: Fast. Forward.

10/09/2025

It’s been another great meeting, and there’s still time to catch up with the team at Booth C03 tomorrow. If you didn’t make it to the conference, we’re always available for an online meeting!

10/07/2025

Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles.

In a Phase I-II study treating glioblastoma and grade 4 astrocytoma at Skåne University Hospital in Sweden, ClearPoint has demonstrated:
- Improved survival compared to matched open surgery controls
- Reproducible workflow with no device-related complications
- Median ablation time of just 6.5 minutes

Visit at Booth 545 and see the results presented in Poster 3560. Product usage represented may not be approved or cleared in all markets.

https://loom.ly/Fv4xNnk

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles October 07, 2025 4:15pm EDT Download as PDF SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 7, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"),....

10/06/2025

Join our Biologics team this week at Booth C03 in Seville, Spain for to hear about our latest innovations and how is leading the way for delivery of gene and cell therapies from discovery to commercialization!